Volatility Shares Trust 2x Ether ETF

iShares Ethereum Trust ETF

Altimmune Inc. Common Stock

AXS 2X Innovation ETF

Defiance Daily Short Digitizing the Economy ETF

Community Bankers Trust Corpora

Direxion Dly S&P Oil&Gs Ex&Prd Bl 3X ETF

Direxion Daily TSLA Bull 1.5X Shares

Direxion Daily Small Cap Bull 3X ETF

ProShares Ultra DJ-AIG Crude Oi

VS TR 2x Long VIX Futures ETF

Direxion Dly S&P Oil&Gs Ex&Prd Br 3X ETF

T-REX 2X Inverse Tesla Daily Target ETF

Direxion Daily Small Cap Bear 3X ETF

MicroSectors Gold Miners 3X Leveraged ETN

ProShares Ultra VIX Short-Term Futures

ProShares Trust ProShares Short Bitcoin Strategy ETF

Direxion Daily Gold Miners Bull 3X ETF

Tuttle Capital Short Innovation ETF

iPath S&P 500 VIX ST Futures ETN

ZK International Group Co. Ltd Ordinary Share

Twin Vee PowerCats Co. Common Stock

Wellgistics Health Inc. Common Stock

Hyperscale Data Inc. Common Stock

Fastly Inc. Class A Common Stock

SolarEdge Technologies Inc. Common Stock

Pinterest Inc. Class A Common Stock

The Trade Desk Inc. Class A Common Stock

Gray Television Inc. Common Stock

DENTSPLY SIRONA Inc. Common Stock

New Century Logistics (BVI) Limited Ordinary Shares

Cleveland-Cliffs Inc. Common Stock

Evolus Inc. Common Stock

PainReform Ltd. Ordinary Shares

First Majestic Silver Corp. Ordinary Shares (Canada)

Phio Pharmaceuticals Corp. Common Stock

Fortinet Inc. Common Stock

Beyond Meat Inc. Common Stock

Eos Energy Enterprises Inc. Class A Common Stock

Altisource Portfolio Solutions S.A. Common Stock

Click here to get full coverage on SCG101 Shows Antiviral and Antitumor Activity in Advanced HBV-Related HCC - OncLive

SCG101 Shows Antiviral and Antitumor Activity in Advanced HBV-Related HCC  OncLive

SCG101 Shows Antiviral and Antitumor Activity in Advanced HBV-Related HCC - OncLive

Click here to get full coverage on Tennis: Rocks clinch unbeaten HCC record, University wins again - ReadTheReporter.com

Tennis: Rocks clinch unbeaten HCC record, University wins again  ReadTheReporter.com

Tennis: Rocks clinch unbeaten HCC record, University wins again - ReadTheReporter.com

Click here to get full coverage on HCC Tumor Burden Score Predicts Long-Term Outcomes Following MWA - AJMC

HCC Tumor Burden Score Predicts Long-Term Outcomes Following MWA  AJMC

HCC Tumor Burden Score Predicts Long-Term Outcomes Following MWA - AJMC

Click here to get full coverage on Risk profiling for cirrhosis and hepatocellular carcinoma in HFE hemochromatosis using mobilizable iron stores and alcohol consumption - Nature

Risk profiling for cirrhosis and hepatocellular carcinoma in HFE hemochromatosis using mobilizable iron stores and alcohol consumption  Nature

Risk profiling for cirrhosis and hepatocellular carcinoma in HFE hemochromatosis using mobilizable iron stores and alcohol consumption - Nature

Click here to get full coverage on Hovione & Firstgene Partner on HCC Targeted Therapy - Contract Pharma

Hovione & Firstgene Partner on HCC Targeted Therapy  Contract Pharma

Hovione & Firstgene Partner on HCC Targeted Therapy - Contract Pharma

Click here to get full coverage on Clinical Profile and Outcome of Patients With Advanced Hepatocellular Carcinoma (HCC) Taking Sorafenib or Lenvatinib: Real-World Experience From a Low-Middle Resource Country - Cureus

Clinical Profile and Outcome of Patients With Advanced Hepatocellular Carcinoma (HCC) Taking Sorafenib or Lenvatinib: Real-World Experience From a Low-Middle Resource Country  Cureus

Clinical Profile and Outcome of Patients With Advanced Hepatocellular Carcinoma (HCC) Taking Sorafenib or Lenvatinib: Real-World Experience From a Low-Middle Resource Country - Cureus

Click here to get full coverage on Sepsis and HCCs – Too Many or Too Few? - RACmonitor

Sepsis and HCCs – Too Many or Too Few?  RACmonitor

Sepsis and HCCs – Too Many or Too Few? - RACmonitor

Click here to get full coverage on An elevated percentage of CD4⁺CD25⁺CD127low regulatory T cells in peripheral blood indicates a poorer prognosis in hepatocellular carcinoma after curative hepatectomy - BMC Gastroenterology

An elevated percentage of CD4⁺CD25⁺CD127low regulatory T cells in peripheral blood indicates a poorer prognosis in hepatocellular carcinoma after curative hepatectomy  BMC Gastroenterology

An elevated percentage of CD4⁺CD25⁺CD127low regulatory T cells in peripheral blood indicates a poorer prognosis in hepatocellular carcinoma after curative hepatectomy - BMC Gastroenterology

Click here to get full coverage on HCC Launches Investigation into Ferry Sector over Alleged Unfair Practices - tovima.com

HCC Launches Investigation into Ferry Sector over Alleged Unfair Practices  tovima.com

HCC Launches Investigation into Ferry Sector over Alleged Unfair Practices - tovima.com

Click here to get full coverage on #HCC Q4 Results | Net profit slumps 63% to ₹90 crore, revenue slides 23% #4QWithCNBCTV18 - LinkedIn

#HCC Q4 Results | Net profit slumps 63% to ₹90 crore, revenue slides 23% #4QWithCNBCTV18  LinkedIn

#HCC Q4 Results | Net profit slumps 63% to ₹90 crore, revenue slides 23% #4QWithCNBCTV18 - LinkedIn

Click here to get full coverage on Hepion Pharmaceuticals Executes Binding Letter of Intent with New Day Diagnostics to Commercialize Diagnostic Tests for Celiac Disease, Respiratory Multiplex, H. Pylori and HCC - Stock Titan

Hepion Pharmaceuticals Executes Binding Letter of Intent with New Day Diagnostics to Commercialize Diagnostic Tests for Celiac Disease, Respiratory Multiplex, H. Pylori and HCC  Stock Titan

Hepion Pharmaceuticals Executes Binding Letter of Intent with New Day Diagnostics to Commercialize Diagnostic Tests for Celiac Disease, Respiratory Multiplex, H. Pylori and HCC - Stock Titan

Click here to get full coverage on Bonvillain to commence May 17 HCC ceremony - The Monroe Times

Bonvillain to commence May 17 HCC ceremony  The Monroe Times

Bonvillain to commence May 17 HCC ceremony - The Monroe Times

Click here to get full coverage on HCC enrollment spikes, program expansion continues - The Mountaineer

HCC enrollment spikes, program expansion continues  The Mountaineer

HCC enrollment spikes, program expansion continues - The Mountaineer

Click here to get full coverage on HCC announces memorial scholarship for Ben Self - Kentucky New Era

HCC announces memorial scholarship for Ben Self  Kentucky New Era

HCC announces memorial scholarship for Ben Self - Kentucky New Era

Click here to get full coverage on HCC officials highlight federal, state support at National Apprenticeship Day event - Community Impact

HCC officials highlight federal, state support at National Apprenticeship Day event  Community Impact

HCC officials highlight federal, state support at National Apprenticeship Day event - Community Impact

Click here to get full coverage on Botensilimab Plus Balstilimab Elicits Durable Responses in Treatment-Refractory HCC - OncLive

Botensilimab Plus Balstilimab Elicits Durable Responses in Treatment-Refractory HCC  OncLive

Botensilimab Plus Balstilimab Elicits Durable Responses in Treatment-Refractory HCC - OncLive

Click here to get full coverage on HCC Q4 Results | Net profit slumps 63% to ₹90 crore, revenue slides 23% - CNBC TV18

HCC Q4 Results | Net profit slumps 63% to ₹90 crore, revenue slides 23%  CNBC TV18

HCC Q4 Results | Net profit slumps 63% to ₹90 crore, revenue slides 23% - CNBC TV18

Click here to get full coverage on FDA Approves Nivolumab/Ipilimumab for Metastatic or Unresectable HCC - Oncology Nursing News

FDA Approves Nivolumab/Ipilimumab for Metastatic or Unresectable HCC  Oncology Nursing News

FDA Approves Nivolumab/Ipilimumab for Metastatic or Unresectable HCC - Oncology Nursing News

Click here to get full coverage on Survival in patients receiving reduced dose intensity of bevacizumab for unresectable hepatocellular carcinoma - Nature

Survival in patients receiving reduced dose intensity of bevacizumab for unresectable hepatocellular carcinoma  Nature

Survival in patients receiving reduced dose intensity of bevacizumab for unresectable hepatocellular carcinoma - Nature

Click here to get full coverage on Nivolumab Plus Ipilimumab Receives EC Approval for First-Line Unresectable HCC - OncLive

Nivolumab Plus Ipilimumab Receives EC Approval for First-Line Unresectable HCC  OncLive

Nivolumab Plus Ipilimumab Receives EC Approval for First-Line Unresectable HCC - OncLive

Click here to get full coverage on Tegavivint Demonstrates Preliminary Antitumor Activity, Safety in Advanced HCC - OncLive

Tegavivint Demonstrates Preliminary Antitumor Activity, Safety in Advanced HCC  OncLive

Tegavivint Demonstrates Preliminary Antitumor Activity, Safety in Advanced HCC - OncLive

Click here to get full coverage on Lady Eagles place second at HCC Meet - reporter.net

Lady Eagles place second at HCC Meet  reporter.net

Lady Eagles place second at HCC Meet - reporter.net

Click here to get full coverage on HCC celebrates arts through Literary Journal - Kentucky New Era

HCC celebrates arts through Literary Journal  Kentucky New Era

HCC celebrates arts through Literary Journal - Kentucky New Era

Click here to get full coverage on Nivolumab/Ipilimumab Establishes Unprecedented Efficacy and Safety Standards in Advanced HCC - OncLive

Nivolumab/Ipilimumab Establishes Unprecedented Efficacy and Safety Standards in Advanced HCC  OncLive

Nivolumab/Ipilimumab Establishes Unprecedented Efficacy and Safety Standards in Advanced HCC - OncLive

Click here to get full coverage on Tokio Marine HCC International Appoints Thibaud Hervy as CEO with Simon Button Promoted to International CUO - GlobeNewswire

Tokio Marine HCC International Appoints Thibaud Hervy as CEO with Simon Button Promoted to International CUO  GlobeNewswire

Tokio Marine HCC International Appoints Thibaud Hervy as CEO with Simon Button Promoted to International CUO - GlobeNewswire

Click here to get full coverage on Nivolumab/Ipilimumab Approaches EU Approval in Unresectable or Advanced HCC - OncLive

Nivolumab/Ipilimumab Approaches EU Approval in Unresectable or Advanced HCC  OncLive

Nivolumab/Ipilimumab Approaches EU Approval in Unresectable or Advanced HCC - OncLive

Click here to get full coverage on Tislelizumab Pushes HCC Field Forward With 2024 NCCN Guideline Category 1 Recommendation - OncLive

Tislelizumab Pushes HCC Field Forward With 2024 NCCN Guideline Category 1 Recommendation  OncLive

Tislelizumab Pushes HCC Field Forward With 2024 NCCN Guideline Category 1 Recommendation - OncLive

Click here to get full coverage on HCC asked 1,800 people about changing the community college’s name. Here’s what they said. - Houston Landing

HCC asked 1,800 people about changing the community college’s name. Here’s what they said.  Houston Landing

HCC asked 1,800 people about changing the community college’s name. Here’s what they said. - Houston Landing

Click here to get full coverage on Combination Regimens Make Their Mark in Frontline HCC - OncLive

Combination Regimens Make Their Mark in Frontline HCC  OncLive

Combination Regimens Make Their Mark in Frontline HCC - OncLive

Click here to get full coverage on TACE Plus Drug Combination Effective in Liver Cancer - National Cancer Institute (.gov)

TACE Plus Drug Combination Effective in Liver Cancer  National Cancer Institute (.gov)

TACE Plus Drug Combination Effective in Liver Cancer - National Cancer Institute (.gov)

Click here to get full coverage on Hoboken to partner with HCC to transform former YMCA into modern rec center - Hudson County View

Hoboken to partner with HCC to transform former YMCA into modern rec center  Hudson County View

Hoboken to partner with HCC to transform former YMCA into modern rec center - Hudson County View

Click here to get full coverage on HCC cancels student trip to London, citing fears of Trump immigration crackdown - Houston Landing

HCC cancels student trip to London, citing fears of Trump immigration crackdown  Houston Landing

HCC cancels student trip to London, citing fears of Trump immigration crackdown - Houston Landing

Click here to get full coverage on Tigers win fifth straight Mudsock, remain unbeaten in HCC - ReadTheReporter.com

Tigers win fifth straight Mudsock, remain unbeaten in HCC  ReadTheReporter.com

Tigers win fifth straight Mudsock, remain unbeaten in HCC - ReadTheReporter.com

Click here to get full coverage on Hepatocellular carcinoma: signaling pathways and therapeutic advances | Signal Transduction and Targeted Therapy - Nature

Hepatocellular carcinoma: signaling pathways and therapeutic advances | Signal Transduction and Targeted Therapy  Nature

Hepatocellular carcinoma: signaling pathways and therapeutic advances | Signal Transduction and Targeted Therapy - Nature

Click here to get full coverage on Amezalpat Gains FDA Orphan Drug Status in HCC - Targeted Oncology

Amezalpat Gains FDA Orphan Drug Status in HCC  Targeted Oncology

Amezalpat Gains FDA Orphan Drug Status in HCC - Targeted Oncology

Click here to get full coverage on RZ-001 Earns FDA Fast Track Designation in HCC - OncLive

RZ-001 Earns FDA Fast Track Designation in HCC  OncLive

RZ-001 Earns FDA Fast Track Designation in HCC - OncLive

Click here to get full coverage on Interest in HCC’s most popular degree is plummeting — and that’s by design - Houston Landing

Interest in HCC’s most popular degree is plummeting — and that’s by design  Houston Landing

Interest in HCC’s most popular degree is plummeting — and that’s by design - Houston Landing

Click here to get full coverage on Unresectable HCC with Post-TACE Progression - Targeted Oncology

Unresectable HCC with Post-TACE Progression  Targeted Oncology

Unresectable HCC with Post-TACE Progression - Targeted Oncology

Click here to get full coverage on Warrior Met Coal (NYSE:HCC) Is Due To Pay A Dividend Of $0.08 - Yahoo Finance

Warrior Met Coal (NYSE:HCC) Is Due To Pay A Dividend Of $0.08  Yahoo Finance

Warrior Met Coal (NYSE:HCC) Is Due To Pay A Dividend Of $0.08 - Yahoo Finance

Click here to get full coverage on Houston Community College enrollment soars in the suburbs, shrinks in the city - Houston Landing

Houston Community College enrollment soars in the suburbs, shrinks in the city  Houston Landing

Houston Community College enrollment soars in the suburbs, shrinks in the city - Houston Landing

Click here to get full coverage on John Snow Labs Unveils New AI-Powered HCC Coding Engine to - GlobeNewswire

John Snow Labs Unveils New AI-Powered HCC Coding Engine to  GlobeNewswire

John Snow Labs Unveils New AI-Powered HCC Coding Engine to - GlobeNewswire

Click here to get full coverage on Faculty union accuses Howard Community College leaders of seeking to suppress ‘union speech’ - The Baltimore Banner

Faculty union accuses Howard Community College leaders of seeking to suppress ‘union speech’  The Baltimore Banner

Faculty union accuses Howard Community College leaders of seeking to suppress ‘union speech’ - The Baltimore Banner

Click here to get full coverage on Green jackfruit flour ameliorates MASH and development of HCC via the AMPK and MAPK signaling pathways in experimental model systems - Nature

Green jackfruit flour ameliorates MASH and development of HCC via the AMPK and MAPK signaling pathways in experimental model systems  Nature

Green jackfruit flour ameliorates MASH and development of HCC via the AMPK and MAPK signaling pathways in experimental model systems - Nature

Click here to get full coverage on Validation study examines accuracy of the GALAD score algorithm for diagnosing HCC in sub-Saharan Africans - Mayo Clinic

Validation study examines accuracy of the GALAD score algorithm for diagnosing HCC in sub-Saharan Africans  Mayo Clinic

Validation study examines accuracy of the GALAD score algorithm for diagnosing HCC in sub-Saharan Africans - Mayo Clinic

Click here to get full coverage on Fritos for lunch, Skittles for dinner: Many HCC students can’t get fresh meals on campus - Houston Landing

Fritos for lunch, Skittles for dinner: Many HCC students can’t get fresh meals on campus  Houston Landing

Fritos for lunch, Skittles for dinner: Many HCC students can’t get fresh meals on campus - Houston Landing

Click here to get full coverage on Help wanted: Many HCC international students scramble for work, but few get it - Houston Landing

Help wanted: Many HCC international students scramble for work, but few get it  Houston Landing

Help wanted: Many HCC international students scramble for work, but few get it - Houston Landing

Click here to get full coverage on SAR444200 Demonstrates Safety, Signals of Clinical Activity in Advanced GPC3+ HCC, Other Solid Tumors - OncLive

SAR444200 Demonstrates Safety, Signals of Clinical Activity in Advanced GPC3+ HCC, Other Solid Tumors  OncLive

SAR444200 Demonstrates Safety, Signals of Clinical Activity in Advanced GPC3+ HCC, Other Solid Tumors - OncLive

Click here to get full coverage on Here’s Black Bear Value Fund’s Update on Warrior Met Coal (HCC) - Yahoo Finance

Here’s Black Bear Value Fund’s Update on Warrior Met Coal (HCC)  Yahoo Finance

Here’s Black Bear Value Fund’s Update on Warrior Met Coal (HCC) - Yahoo Finance

Click here to get full coverage on The epigenetic basis of hepatocellular carcinoma – mechanisms and potential directions for biomarkers and therapeutics | British Journal of Cancer - Nature

The epigenetic basis of hepatocellular carcinoma – mechanisms and potential directions for biomarkers and therapeutics | British Journal of Cancer  Nature

The epigenetic basis of hepatocellular carcinoma – mechanisms and potential directions for biomarkers and therapeutics | British Journal of Cancer - Nature

Click here to get full coverage on FDA Grants Orphan Drug Designation to Amezalpat for Advanced HCC - OncLive

FDA Grants Orphan Drug Designation to Amezalpat for Advanced HCC  OncLive

FDA Grants Orphan Drug Designation to Amezalpat for Advanced HCC - OncLive

Click here to get full coverage on HCC had big plans for a $30M natural disaster training facility. Why wasn’t it built? - Houston Landing

HCC had big plans for a $30M natural disaster training facility. Why wasn’t it built?  Houston Landing

HCC had big plans for a $30M natural disaster training facility. Why wasn’t it built? - Houston Landing

Click here to get full coverage on Development of a MVI associated HCC prognostic model through single cell transcriptomic analysis and 101 machine learning algorithms - Nature

Development of a MVI associated HCC prognostic model through single cell transcriptomic analysis and 101 machine learning algorithms  Nature

Development of a MVI associated HCC prognostic model through single cell transcriptomic analysis and 101 machine learning algorithms - Nature

Click here to get full coverage on Lenvatinib Shows Efficacy in Advanced HCC Post-Progression on Atezolizumab/Bevacizumab - OncLive

Lenvatinib Shows Efficacy in Advanced HCC Post-Progression on Atezolizumab/Bevacizumab  OncLive

Lenvatinib Shows Efficacy in Advanced HCC Post-Progression on Atezolizumab/Bevacizumab - OncLive

Click here to get full coverage on HCC board votes to settle anti-discrimination suits in tense meeting - Houston Chronicle

HCC board votes to settle anti-discrimination suits in tense meeting  Houston Chronicle

Warrior Met Coal Inc (HCC)

Price Chart

Key Statistics

Technicals

About HCC

Latest News

SCG101 Shows Antiviral and Antitumor Activity in Advanced HBV-Related HCC - OncLive

Tennis: Rocks clinch unbeaten HCC record, University wins again - ReadTheReporter.com

HCC Tumor Burden Score Predicts Long-Term Outcomes Following MWA - AJMC

Advanced Charts

Top Gainers

Top Losers